In microsatellite stable colorectal cancer, butyrate produced by Fusobacterium inhibits histone deacetylase in CD8+ T-cells, inducing the expression of the TBX21 gene, which suppresses PD-1 expression, alleviates T-cell exhaustion, and thus enhances the efficacy of immunotherapy (48). Here, CD8A is linked to colorectal cancer.